FDA Rejects Device Industry's Two-Year User Fee Plan
This article was originally published in The Gray Sheet
Executive Summary
FDA says industry's reluctance to put a five-year user fee reauthorization plan on the table for discussion is delaying progress toward 2012 user fee legislation.